SCHEMBL21926239

SCHEMBL21926239

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4cccc5c4sc4c5ccc5c4c4ccccc4n5-c4ccccc4)cc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ ATM Q13315 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ LIMK1 P53667 1/20 0.37
▸ MAPK14 Q16539 1/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ IL1R1 P14778 1/20 0.32
▸ MEN1 O00255 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ HTT P42858 1/20 0.31
▸ ALOX5 P09917 1/20 0.31
▸ ABCG2 Q9UNQ0 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31
▸ TP53 P04637 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ NFKB2 Q00653 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15745477 0.98 LIMK1 (0.37) L3MBTL1ATMKDM4ELIMK1MAPK14
SCHEMBL21926229 0.97 LIMK1 (0.36) L3MBTL1ATMKDM4ELIMK1MAPK14
SCHEMBL21925592 0.94 KDM4E (0.37) L3MBTL1ATMKDM4ELIMK1KMT2A
SCHEMBL21926570 0.94 KDM4E (0.37) L3MBTL1ATMKDM4ELIMK1KMT2A
SCHEMBL16978593 0.94 KDM4E (0.39) L3MBTL1ATMKDM4ELIMK1MAPK14
SCHEMBL21928011 0.94 MAPT (0.36) L3MBTL1ATMKDM4ELIMK1KMT2A
SCHEMBL21928013 0.94 MAPT (0.36) L3MBTL1ATMKDM4ELIMK1KMT2A
SCHEMBL21925594 0.93 KDM4E (0.36) L3MBTL1ATMKDM4ELIMK1MAPK14
SCHEMBL21928019 0.93 KDM4E (0.36) L3MBTL1ATMKDM4ELIMK1KMT2A
SCHEMBL21926228 0.92 LIMK1 (0.35) L3MBTL1ATMKDM4ELIMK1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690288-B2 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device SAMSUNG SDI CO., LTD. (KR) 2023-06-27 — — US disclosed
US-11690288-B2 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device SAMSUNG SDI CO., LTD. (KR) 2023-06-27 — — US disclosed
US-20200136057-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136057-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DIODE, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE OR10J3, OCIAD2, OR51E2 L3MBTL1 2491/4885ATM 3602/4885KDM4E 3744/4885
US-11690288-B2 Composition for organic optoelectronic diode, organic optoelectronic diode, and display device OR10J3, OCIAD2, OR51E2 L3MBTL1 2491/4885ATM 3602/4885KDM4E 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback